Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Questions Circle INDs; Industry Needs Guidance For Probiotics, Say Experts

This article was originally published in The Tan Sheet

Executive Summary

FDA should consider issuing a guidance for probiotics similar to the 2004 industry guidance for botanical drugs, panelists said at a recent Drug Information Association conference

You may also be interested in...



Taiwan Biotech Touts Drug Derived From Chinese Medicine To Treat Cancer Patients

Taiwan’s Maywufa Bio Pharmaceutical Group launched a cancer-related fatigue treatment derived from an herb used in traditional Chinese medicine and plans to investigate it for cardiovascular use with clinical trials in the United States.

CAM Guidance Statement On Probiotics Is “Astonishing,” Concerns Experts

FDA's Center for Biologics Evaluation and Research may be laying the groundwork for greater control of the regulation of probiotics in the agency's recently released guidance document on "complementary and alternative medicine products," according to industry stakeholders

CAM Guidance Statement On Probiotics Is “Astonishing,” Concerns Experts

FDA's Center for Biologics Evaluation and Research may be laying the groundwork for greater control of the regulation of probiotics in the agency's recently released guidance document on "complementary and alternative medicine products," according to industry stakeholders

Related Content

Topics

UsernamePublicRestriction

Register

LL029263

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel